BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 26271194)

  • 1. Suitability Criteria for Adult Related Donors: A Consensus Statement from the Worldwide Network for Blood and Marrow Transplantation Standing Committee on Donor Issues.
    Worel N; Buser A; Greinix HT; Hägglund H; Navarro W; Pulsipher MA; Nicoloso de Faveri G; Bengtsson M; Billen A; Espino G; Fechter M; Giudice V; Hölig K; Kanamori H; Kodera Y; Leitner G; Netelenbos T; Niederwieser D; van Walraven SM; Rocha V; Torosian T; Vergueiro C; Weisdorf D; Yabe H; Halter JP
    Biol Blood Marrow Transplant; 2015 Dec; 21(12):2052-2060. PubMed ID: 26271194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suitability of haematopoietic cell donors: updated consensus recommendations from the WBMT standing committee on donor issues.
    Worel N; Aljurf M; Anthias C; Buser AS; Cody M; Fechter M; Galeano S; Greinix HT; Kisch AM; Koh MBC; Mengling T; Nicoloso G; Niederwieser D; Pulsipher MA; Seber A; Shaw BE; Stefanski HE; Switzer GE; Szer J; van Walraven SM; Yang H; Halter JP
    Lancet Haematol; 2022 Aug; 9(8):e605-e614. PubMed ID: 35901845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stem-cell transplantation in children with acute lymphoblastic leukemia: A prospective international multicenter trial comparing sibling donors with matched unrelated donors-The ALL-SCT-BFM-2003 trial.
    Peters C; Schrappe M; von Stackelberg A; Schrauder A; Bader P; Ebell W; Lang P; Sykora KW; Schrum J; Kremens B; Ehlert K; Albert MH; Meisel R; Matthes-Martin S; Gungor T; Holter W; Strahm B; Gruhn B; Schulz A; Woessmann W; Poetschger U; Zimmermann M; Klingebiel T
    J Clin Oncol; 2015 Apr; 33(11):1265-74. PubMed ID: 25753432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes from unrelated donor hematopoietic stem cell transplantation.
    Perez LE
    Cancer Control; 2011 Oct; 18(4):216-21. PubMed ID: 21976240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation.
    Faridi RM; Kemp TJ; Dharmani-Khan P; Lewis V; Tripathi G; Rajalingam R; Daly A; Berka N; Storek J; Masood Khan F
    PLoS One; 2016; 11(6):e0158242. PubMed ID: 27341514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of Eligibility in Related Pediatric Hematopoietic Cell Donors: Ethical and Clinical Considerations. Recommendations from a Working Group of the Worldwide Network for Blood and Marrow Transplantation Association.
    Bitan M; van Walraven SM; Worel N; Ball LM; Styczynski J; Torrabadella M; Witt V; Shaw BE; Seber A; Yabe H; Greinix HT; Peters C; Gluckman E; Rocha V; Halter J; Pulsipher MA
    Biol Blood Marrow Transplant; 2016 Jan; 22(1):96-103. PubMed ID: 26307344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mismatched related and unrelated donors for allogeneic hematopoietic cell transplantation for adults with hematologic malignancies.
    Eapen M; O'Donnell P; Brunstein CG; Wu J; Barowski K; Mendizabal A; Fuchs EJ
    Biol Blood Marrow Transplant; 2014 Oct; 20(10):1485-92. PubMed ID: 24862638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unmanipulated haploidentical transplants compared with other alternative donors and matched sibling grafts.
    Raiola AM; Dominietto A; di Grazia C; Lamparelli T; Gualandi F; Ibatici A; Bregante S; Van Lint MT; Varaldo R; Ghiso A; Gobbi M; Carella AM; Signori A; Galaverna F; Bacigalupo A
    Biol Blood Marrow Transplant; 2014 Oct; 20(10):1573-9. PubMed ID: 24910379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unrelated donor transplantation: peripheral blood or bone marrow--does it matter?
    Eapen M
    Best Pract Res Clin Haematol; 2014; 27(3-4):278-82. PubMed ID: 25455278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allogeneic marrow stem-cell transplantation from human leukocyte antigen-identical siblings versus human leukocyte antigen-allelic-matched unrelated donors (10/10) in patients with standard-risk hematologic malignancy: a prospective study from the French Society of Bone Marrow Transplantation and Cell Therapy.
    Yakoub-Agha I; Mesnil F; Kuentz M; Boiron JM; Ifrah N; Milpied N; Chehata S; Esperou H; Vernant JP; Michallet M; Buzyn A; Gratecos N; Cahn JY; Bourhis JH; Chir Z; Raffoux C; Socié G; Golmard JL; Jouet JP;
    J Clin Oncol; 2006 Dec; 24(36):5695-702. PubMed ID: 17116940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Selection of an unrelated donor for hematopoietic stem cell transplantation. HLA haplotypes in patients with blood system diseases].
    Khamaganova EG; Parovichnikova EN; Kuz'mina LA; Gemdzhian ÉG; Chugreeva TP; Iushkova AA
    Ter Arkh; 2014; 86(7):31-6. PubMed ID: 25314775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donor selection process for allogeneic hematopoietic stem cell transplantation at the university hospital of Düsseldorf (1997-1998).
    Enczmann J; Rinker M; Kiesel U; Kuhröber A; Kögler G; Nürnberger W; Göbel U; Wernet P
    Klin Padiatr; 1999; 211(4):218-23. PubMed ID: 10472554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell-replete HLA-haploidentical hematopoietic transplantation for hematologic malignancies using post-transplantation cyclophosphamide results in outcomes equivalent to those of contemporaneous HLA-matched related and unrelated donor transplantation.
    Bashey A; Zhang X; Sizemore CA; Manion K; Brown S; Holland HK; Morris LE; Solomon SR
    J Clin Oncol; 2013 Apr; 31(10):1310-6. PubMed ID: 23423745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total Body Irradiation-Based Myeloablative Haploidentical Stem Cell Transplantation Is a Safe and Effective Alternative to Unrelated Donor Transplantation in Patients Without Matched Sibling Donors.
    Solomon SR; Sizemore CA; Sanacore M; Zhang X; Brown S; Holland HK; Morris LE; Bashey A
    Biol Blood Marrow Transplant; 2015 Jul; 21(7):1299-307. PubMed ID: 25797174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparable long-term outcome of unrelated cord blood transplantation with related bone marrow or peripheral blood stem cell transplantation in patients aged 45 years or older with hematologic malignancies after myeloablative conditioning.
    Konuma T; Kato S; Ooi J; Oiwa-Monna M; Kawamata T; Tojo A; Takahashi S
    Biol Blood Marrow Transplant; 2014 Aug; 20(8):1150-5. PubMed ID: 24727335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unrelated cord blood compared with haploidentical grafts in patients with hematological malignancies.
    El-Cheikh J; Crocchiolo R; Furst S; Bramanti S; Sarina B; Granata A; Vai A; Lemarie C; Faucher C; Mohty B; Harbi S; Bouabdallah R; Vey N; Santoro A; Chabannon C; Castagna L; Blaise D
    Cancer; 2015 Jun; 121(11):1809-16. PubMed ID: 25649994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unrelated adult stem cell donor medical suitability: recommendations from the World Marrow Donor Association Clinical Working Group Committee.
    Lown RN; Philippe J; Navarro W; van Walraven SM; Philips-Johnson L; Fechter M; Pawson R; Bengtsson M; Beksac M; Field S; Yang H; Shaw BE;
    Bone Marrow Transplant; 2014 Jul; 49(7):880-6. PubMed ID: 24710563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic effect of major histocompatibility complex class I-related chain a and human leukocyte antigen-DPB1 mismatches in association with acute graft-versus-host disease after unrelated donor hematopoietic stem cell transplantation.
    Askar M; Sun Y; Rybicki L; Zhang A; Thomas D; Kalaycio M; Pohlman B; Dean R; Duong H; Hanna R; Maciejewski J; Majhail NS; Bolwell B; Sobecks R
    Biol Blood Marrow Transplant; 2014 Nov; 20(11):1835-40. PubMed ID: 25064744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic hematopoietic stem cell donation-standardized assessment of donor outcome data: a consensus statement from the Worldwide Network for Blood and Marrow Transplantation (WBMT).
    Halter JP; van Walraven SM; Worel N; Bengtsson M; Hägglund H; Nicoloso de Faveri G; Shaw BE; Schmidt AH; Fechter M; Madrigal A; Szer J; Aljurf MD; Weisdorf D; Horowitz MM; Greinix H; Niederwieser D; Gratwohl A; Kodera Y; Confer D
    Bone Marrow Transplant; 2013 Feb; 48(2):220-5. PubMed ID: 22773129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.